World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
107
Citations
41140
World Ranking
6270
National Ranking
199

Overview

Andrea Bacigalupo is affiliated with the Catholic University of the Sacred Heart in Italy. Their primary research field is Medicine, with a total of 274 publications. The main subfields of their study include Hematology, Oncology, Genetics, Immunology, and Public Health, Environmental and Occupational Health. Within these fields, their work focuses extensively on hematopoietic stem cell transplantation and related diseases.

The scientist's research topics include:

  • Hematopoietic Stem Cell Transplantation
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Polyomavirus and related diseases
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Renal Transplantation Outcomes and Treatments

Andrea Bacigalupo has published frequently in several specialized venues. The most common publication outlets are:

  • Bone Marrow Transplantation
  • Blood
  • Mediterranean Journal of Hematology and Infectious Diseases
  • Haematologica
  • Zenodo (CERN European Organization for Nuclear Research)

Among their recent papers are:

  • Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation, 2020, The Lancet Haematology
  • Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes, 2021, Journal of Clinical Oncology
  • Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel, 2020, Bone Marrow Transplantation
  • Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis, 2021, The Lancet Oncology
  • Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group, 2023, The Lancet Haematology

Their scholarly network includes frequent collaborations with other researchers. Regular co-authors include:

  • Patrizia Chiusolo
  • Simona Sica
  • Sabrina Giammarco
  • Elisabetta Metafuni
  • Federica Sorà

Best Publications

  • Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

    Katarina Le Blanc;Francesco Frassoni;Lynne Ball;Franco Locatelli

  • Defining the intensity of conditioning regimens: working definitions.

    Andrea Bacigalupo;Karen Ballen;Doug Rizzo;Sergio Giralt

  • Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients

    Hillard M. Lazarus;Omer N. Koc;Steven M. Devine;Peter Curtin

  • Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors

    Sebastian Giebel;Franco W Locatelli;Teresa Lamparelli;Andrea Velardi

  • Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.

    Socié G;Henry-Amar M;Bacigalupo A;Hows J

  • Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)

    Andrea Bacigalupo;Teresa Lamparelli;Paolo Bruzzi;Stefano Guidi

  • Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

    Olaf Penack;Monia Marchetti;Tapani Ruutu;Mahmoud Aljurf

  • Philadelphia chromosome-negative classical myeloproliferative neoplasms: Revised management recommendations from European LeukemiaNet

    Tiziano Barbui;Ayalew Tefferi;Alessandro M. Vannucchi;Francesco Passamonti

  • Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112).

    Daniela Pende;Grazia Maria Spaggiari;Stefania Marcenaro;Stefania Martini

  • Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT

    Joost W. J. van Esser;Bronno van der Holt;Ellen Meijer;Hubert G. M. Niesters

  • Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning

    Anna Maria Raiola;Alida Dominietto;Anna Ghiso;Carmen Di Grazia

  • Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.

    Rodrigo Martino;Simona Iacobelli;Ronald Brand;Thekla Jansen

  • Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.

    Andrea Bacigalupo;Teresa Lamparelli;Giovanni Barisione;Paolo Bruzzi

  • Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).

    Anna Locasciulli;Rosi Oneto;Andrea Bacigalupo;Gerard Socie

  • Allogeneic Stem Cell Transplantation for Agnogenic Myeloid Metaplasia: A European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study

    P. Guardiola;J. Anderson;G. Bandini;F. Cervantes

  • A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease

    Mary E D Flowers;Jane F. Apperley;Koen Van Besien;Ahmet Elmaagacli

  • Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience.

    Andrea Bacigalupo;Ronald Brand;Rosi Oneto;Barbara Bruno

  • How I treat acquired aplastic anemia.

    Andrea Bacigalupo

  • Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients.

    Maria Galotto;Giovanni Berisso;Laura Delfino;Marina Podesta

  • Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia

    ZiYi Lim;Ronald Brand;Rodrigo Martino;Anja van Biezen

Frequent Co-Authors

Gérard Socié
Gérard Socié Université Paris Cité
Alessandro Rambaldi
Alessandro Rambaldi University of Milan
Jakob Passweg
Jakob Passweg University Hospital of Basel
Fabio Ciceri
Fabio Ciceri Vita-Salute San Raffaele University
Francesca Gualandi
Francesca Gualandi University of Ferrara
Judith C. W. Marsh
Judith C. W. Marsh King's College London
Alberto Bosi
Alberto Bosi University of Florence
Arnon Nagler
Arnon Nagler Sheba Medical Center
Myriam Labopin
Myriam Labopin Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The landscape of healthcare education is rapidly evolving, offering a variety of online programs for individuals seeking to expand their qualifications or transition into new fields. Choosing the right pathway depends on your career aspirations, current educational background, and budget.

Administrative roles, such as hospital management or policy development, often require advanced credentials. If you’re interested in advancing to leadership roles, consider a masters in healthcare administration cost as an important factor for long-term value and affordability.

For nursing professionals aiming for the highest level of clinical practice, the cheapest bsn to dnp programs can offer a flexible, cost-effective route to a Doctor of Nursing Practice. Similarly, those interested in pharmacy careers may explore accelerated 3 year online pharmd programs.

If your interest lies at the intersection of healthcare and technology, a health information management bachelor degree online can open doors in data management, compliance, and informatics. With so many affordable online options, aspiring professionals can more easily find programs that suit their professional goals and financial circumstances.

Best Scientists Citing Andrea Bacigalupo

Trending Scientists

Recently Published Articles